|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
|
US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US7374768B1
(en)
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
|
US6309647B1
(en)
*
|
1999-07-15 |
2001-10-30 |
Aventis Pasteur |
Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
|
|
EP0561034B1
(en)
*
|
1991-08-26 |
1999-06-09 |
IMMUNO Aktiengesellschaft |
Direct molecular cloning of a modified chordopox virus genome
|
|
WO1995030018A2
(en)
*
|
1994-04-29 |
1995-11-09 |
Immuno Aktiengesellschaft |
Recombinant poxviruses with foreign polynucleotides in essential regions
|
|
FR2750865B1
(fr)
*
|
1996-06-27 |
1998-12-04 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
|
|
US7294338B2
(en)
*
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
US6368603B1
(en)
*
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
|
FR2775601B1
(fr)
*
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
|
ATE391726T1
(de)
|
1999-10-22 |
2008-04-15 |
Sanofi Pasteur Ltd |
Modifiziertes gp100 und dessen verwendung
|
|
WO2001045735A2
(en)
*
|
1999-12-21 |
2001-06-28 |
Merial |
Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
|
|
US20030027246A1
(en)
*
|
2000-03-31 |
2003-02-06 |
Artur Pedyczak |
Immunogenic peptides derived from prostate-specific membrane antigen (PSMA) and uses thereof
|
|
PT1282702E
(pt)
|
2000-05-10 |
2007-02-28 |
Ludwig Inst Cancer Res |
Polipéptidos imunogénicos codificados por minigenes mage e suas utilizações
|
|
US7097842B2
(en)
*
|
2000-11-23 |
2006-08-29 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
JP4421188B2
(ja)
*
|
2000-11-23 |
2010-02-24 |
バヴァリアン・ノルディック・アクティーゼルスカブ |
変性ワクシニアアンカラウイルス変異体
|
|
US7628980B2
(en)
*
|
2000-11-23 |
2009-12-08 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US20030228327A1
(en)
*
|
2001-11-05 |
2003-12-11 |
Lasher Alfred W. |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
US20070269456A1
(en)
*
|
2001-11-05 |
2007-11-22 |
Lasher Alfred W |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
JP4801880B2
(ja)
*
|
2002-04-19 |
2011-10-26 |
バヴァリアン・ノルディック・アクティーゼルスカブ |
新生仔予防接種用変異ワクシニアウイルスアンカラ
|
|
EP1499635B8
(en)
|
2002-05-02 |
2014-04-16 |
David Lovejoy |
Teneurin c-terminal associated peptides (tcap) and uses thereof
|
|
ATE393212T2
(de)
*
|
2002-09-05 |
2008-05-15 |
Bavarian Nordic As |
Verfahren zur amplifikation von einem poxvirus in serumfreien verhältnissen
|
|
EP1572985A4
(en)
*
|
2002-12-13 |
2008-03-19 |
Aventis Pasteur Inc |
ALVAC PRODUCTION ON AVIAN STEM CELLS
|
|
US8663622B2
(en)
*
|
2002-12-16 |
2014-03-04 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Recombinant vaccine viruses expressing IL-15 and methods using the same
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
US20060240039A1
(en)
*
|
2003-06-13 |
2006-10-26 |
Isis Innovation Limited |
Vaccines
|
|
JP5576010B2
(ja)
|
2003-08-04 |
2014-08-20 |
ザ・ホスピタル・フォー・シック・チルドレン |
ラフォラ病遺伝子
|
|
EP1689858B1
(en)
|
2003-11-13 |
2013-05-15 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
|
WO2005118672A1
(en)
*
|
2004-06-02 |
2005-12-15 |
The Governors Of The University Of Alberta |
Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
|
|
US7998733B2
(en)
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
DK1881845T3
(da)
*
|
2005-04-25 |
2010-06-07 |
Merial Ltd |
Nipah-virusvacciner
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
EP3536704B1
(en)
|
2005-11-14 |
2021-08-25 |
Boehringer Ingelheim Animal Health USA Inc. |
Gene therapy for renal failure
|
|
US7455844B2
(en)
|
2006-03-29 |
2008-11-25 |
Merial Limited |
Vaccine against streptococci
|
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
WO2008064451A1
(en)
*
|
2006-11-30 |
2008-06-05 |
University Of British Columbia |
Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant
|
|
WO2008136790A1
(en)
|
2007-05-02 |
2008-11-13 |
Merial Limited |
Dna plasmids having improved expression and stability
|
|
US8603808B2
(en)
|
2008-05-08 |
2013-12-10 |
Merial Limited |
Leishmania vaccine using sand fly salivary immunogen
|
|
CA2765298A1
(en)
|
2008-06-27 |
2009-12-30 |
University Of Guelph |
Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
|
|
BR122019001455B1
(pt)
|
2008-10-24 |
2021-01-19 |
Merial, Inc. |
vacina contra o vírus da doença equina africana
|
|
CA2829916C
(en)
|
2011-03-21 |
2019-08-20 |
Vaxin Inc. |
Intranasal administration of an adenovirus vector to induce a protective immune response to an inhalation pathogen
|
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
ES2674439T3
(es)
|
2011-06-01 |
2018-06-29 |
Merial, Inc. |
Administración sin aguja de vacunas contra el VSRRP
|
|
AU2012284558B2
(en)
|
2011-07-20 |
2017-06-29 |
Centre National De La Recherche Scientifique |
Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
|
|
CN103841963B
(zh)
|
2011-08-12 |
2018-04-24 |
梅里亚股份有限公司 |
用于生物产品特别是疫苗的真空辅助保存
|
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
|
AU2013221502C1
(en)
|
2012-02-14 |
2018-03-01 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
|
|
NZ700470A
(en)
|
2012-03-20 |
2016-04-29 |
Merial Inc |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
|
|
CN105026422B
(zh)
|
2012-03-27 |
2019-09-27 |
西安大略大学 |
Sh2结构域变体
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
EP2968435B1
(en)
|
2013-03-12 |
2019-01-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Synthetic peptides for the treatment of autoimmune diseases
|
|
WO2016073410A1
(en)
|
2014-11-03 |
2016-05-12 |
Merial, Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
EP3042666A1
(en)
|
2015-01-06 |
2016-07-13 |
Rheinisch-Westfälische Technische Hochschule Aachen |
ITIH5 fragments for the treatment of cancer
|
|
ES2903443T3
(es)
|
2015-04-28 |
2022-04-01 |
Avivagen Inc |
Carotenoides oxidados y componentes de los mismos para prevenir la enteritis necrótica
|
|
TW202203966A
(zh)
*
|
2020-03-31 |
2022-02-01 |
澳大利亞商賽門蒂斯公司 |
用於防範ｃｏｖｉｄ－１９之以減毒的痘病毒載體為底質之疫苗
|
|
CN116656730B
(zh)
*
|
2023-05-25 |
2024-03-19 |
军事科学院军事医学研究院军事兽医研究所 |
一种表达狂犬病病毒g、m蛋白的重组金丝雀痘病毒及其构建方法
|